Tag: Crohn’s Disease
Revolutionary TL1A Therapies Bring New Hope to IBD Patients
Multiple pharmaceutical giants are racing to develop TL1A binder therapies that could revolutionize IBD treatment by targeting inflammation in a completely new way. Early clinical trial results show promising remission and healing rates, offering genuine hope for patients who need better treatment options.
Global IBD Registry Network: Turning Your Story Into Medical Progress
A groundbreaking Global IBD Registry Network is connecting patient data worldwide to accelerate research and improve personalized treatment options. This initiative transforms isolated medical records into powerful insights that could revolutionize IBD care for everyone in our community.
New Oral Crohn’s Therapy Shows Promise in Early Research
Trethera Corporation has developed TRE-515, an oral Crohn’s medication that targets specific immune cells while preserving overall immune function. The NIH has awarded $1.8 million to advance this promising research that could revolutionize how we treat inflammatory bowel disease.
Understanding ‘Creeping Fat’: The Hidden Factor in Crohn’s Complications
New research reveals how ‘creeping fat’ around the intestines actively contributes to strictures and complications in Crohn’s disease. This discovery opens doors to potential new treatments that could prevent these serious complications before they develop.
How Social Connection Transforms Life with Crohn’s Disease
Living with Crohn’s disease can feel isolating, but research shows that strong social support networks significantly improve quality of life and health outcomes for IBD patients. Understanding how to build and maintain these crucial connections can transform your experience with chronic illness.
Prevention in Your Hands: Lifestyle Choices That May Lower Crohn’s Risk
New research reveals that lifestyle choices like following a Mediterranean diet, exercising regularly, avoiding smoking, and managing stress may help lower Crohn’s disease risk. For families touched by IBD, these findings offer hope and actionable prevention strategies.
When IBD Medications Face Competition: J&J’s Stelara Story
Johnson & Johnson’s response to Stelara facing biosimilar competition offers important insights for the IBD community. While sales dropped nearly 50%, their commitment to innovation and record-breaking growth in new treatments suggests promising developments ahead for inflammatory bowel disease patients.
When Well-Meaning Words Wound: Supporting Your IBD Journey
Well-meaning comments like “you don’t look sick” can deeply wound those living with IBD. Understanding the emotional impact of these phrases—and learning better ways to offer support—can transform relationships and reduce the isolation many feel.
Larry Nance Jr.’s Inspiring Journey: Turning Crohn’s Into NBA Success
NBA player Larry Nance Jr.’s journey from a devastating Crohn’s diagnosis at sixteen to professional basketball success offers hope and inspiration for anyone in the IBD community pursuing their dreams. His story proves that with the right support and determination, chronic illness doesn’t have to limit your ambitions.
When Crohn’s Strikes Your Bladder: A Rare but Real Reality
New research reveals that Crohn’s disease can cause bladder ulcers even without the typical fistula connection. This rare manifestation reminds us that IBD is truly a systemic condition that can surprise us in unexpected ways.
